Cite Filings / BVS / 0001628280-23-008191

Feed Companies Filings Check

Sign in

NT 10-K

Filing

Bioventus Inc. Filed 2023-03-16 Acc 0001628280-23-008191

Documents 1

NT 10-K , nt-10k.htm

Around this filing

2023-03-23 4 SVP & CFO acquired 18,625 shares (option exercise)
2023-03-16 NT 10-K NT 10-K
2023-03-16 4 SVP & General Counsel sold 3,409 shares at $1.39 ($4,737)
2023-03-16 4 Director acquired 3,949 shares (option exercise)
2023-03-16 4 Chief Executive Officer sold 9,811 shares at $1.39 ($13,625)
2023-03-16 4 SVP & Chief Compliance Officer sold 1,332 shares at $1.39 ($1,850)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading nt-10k.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…